Strides Arcolab tends to do well in spurts: Ashwani Gujral, Market Strategist

Ashwani Gujral, Chief Market Strategist, ashwanigujral.com, in a chat with ET Now talks about Strides Arcolab.

Have you looked at Strides Arcolab?

Strides is that kind of mid-cap pharma stock which tends to do well in spurts. It was moving in a long range and then suddenly broke down. Now it is starting to move up but probably still needs to cross levels of 399-400 before it can get back into that range of about 400-460.